MedPath

Interest of Re-oxygenation After Inhalation of 50% Nitrous Oxide / 50% Oxygen Premix in Dental Cares

Phase 3
Terminated
Conditions
Dental Cares Under Kalinox's Inhalation
Interventions
Drug: Oxygène
Registration Number
NCT00643786
Lead Sponsor
Air Liquide Santé International
Brief Summary

The usefulness of re-oxygenation after inhalation of 50% nitrous oxide and 50% oxygen premix (Kalinox 170 bar) during dental care is studied and the pollution resulting from administration of Kalinox is also investigated.

Detailed Description

Not available

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
128
Inclusion Criteria
  • From 1 year old
  • anxious or phobic patients
  • very young children requiring selective dental cares
  • mental deficient patients
  • ASA 1 or ASA 2 patients
Exclusion Criteria
  • ASA 3 or ASA 4 patients
  • contraindication linked to the experimental product
  • patients with mental disorder incompatible with the motory test
  • patients that have received anxiolytic treatment less than 2 hours before the dental care

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
AOxygèneOxygène
BAir MédicalAir Médical
Primary Outcome Measures
NameTimeMethod
Measurement of SpO2In continuous
Secondary Outcome Measures
NameTimeMethod
Analysis of ambient air pollution by nitrous oxide and patient's acceptanceIn continuous

Trial Locations

Locations (1)

UFR Odontologie Equipe d'accueil 3847

🇫🇷

Clermont-Ferrand, France

© Copyright 2025. All Rights Reserved by MedPath